Clinical Trial Update: Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on adjuvant astragalus therapy for diabetic kidney disease across Phase 2 and Phase 3 evaluating efficacy, safety, and response predictors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Diabetic Nephropathies

Drugs mentioned

• Astragalus therapy

Snippet

Sponsor: The University of Hong Kong | Conditions: Diabetic Nephropathies, Diabetic Kidney Disease | Phase 2, Phase 3 | Status: UNKNOWN